Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/20616
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBUYSE, Marc-
dc.contributor.authorBURZYKOWSKI, Tomasz-
dc.contributor.authorSaad, Everardo D.-
dc.date.accessioned2016-02-11T14:10:03Z-
dc.date.available2016-02-11T14:10:03Z-
dc.date.issued2016-
dc.identifier.citationCLINICAL CANCER RESEARCH, 22 (1), p. 268-268-
dc.identifier.issn1078-0432-
dc.identifier.urihttp://hdl.handle.net/1942/20616-
dc.language.isoen-
dc.publisherAMER ASSOC CANCER RESEARCH-
dc.titleNeoadjuvant as Future for Drug Development in Breast Cancer-Letter-
dc.typeJournal Contribution-
dc.identifier.epage268-
dc.identifier.issue1-
dc.identifier.spage268-
dc.identifier.volume22-
local.format.pages1-
local.bibliographicCitation.jcatA1-
dc.description.notes[Buyse, Marc] Int Inst Drug Dev, San Francisco, CA USA. [Buyse, Marc; Burzykowski, Tomasz] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Hasselt, Belgium. [Burzykowski, Tomasz; Saad, Everardo D.] Int Inst Drug Dev, Louvain La Neuve, Belgium. [Saad, Everardo D.] Dendrix Res, Sao Paulo, Brazil.-
local.publisher.placePHILADELPHIA-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1158/1078-0432.CCR-15-1047-
dc.identifier.isi000367550300030-
item.contributorBUYSE, Marc-
item.contributorBURZYKOWSKI, Tomasz-
item.contributorSaad, Everardo D.-
item.accessRightsClosed Access-
item.fullcitationBUYSE, Marc; BURZYKOWSKI, Tomasz & Saad, Everardo D. (2016) Neoadjuvant as Future for Drug Development in Breast Cancer-Letter. In: CLINICAL CANCER RESEARCH, 22 (1), p. 268-268.-
item.validationecoom 2017-
item.fulltextNo Fulltext-
crisitem.journal.issn1078-0432-
crisitem.journal.eissn1557-3265-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.